Enrollment delays and retention failures threaten ophthalmic clinical trials. The main issue is execution barriers. Participants cannot access specialized BCVA, IOP, and OCT assessments due to the...
Read More
Accessibility barriers create enrollment failures in otherwise well-designed trials. When participants cannot reach sites due to distance, transportation limitations, mobility challenges, or...
Read More
Clinical research logistics in ophthalmic trials are not just about moving equipment or scheduling visits. They directly affect endpoint quality. When intraocular pressure (IOP), best corrected...
Read More
Ocular endpoints can become a failure point in otherwise well-designed clinical trials. When IOP measurements vary across sites, OCT imaging is not captured consistently, or BCVA assessments are not...
Read More
Key Takeaways A failed OCT scan in retina clinical trials does not just cost a rescan. It costs a visit window, a deviation filing, and sometimes the patient. The invoice never shows full damage....
Read More
In ophthalmology trials, dropout is often treated like an unfortunate reality. In practice, it is usually more predictable than teams assume and more preventable than protocols reflect.
Read More
In clinical trials that deal with ocular hypertension, intraocular pressure (IOP) is not just a measurement. It is often the primary determinant of regulatory credibility and treatment response...
Read More